Design, synthesis and evaluation of inhibitors against tumour-associated protease

Proteases are a class of physiologically active proteins which lead different biochemistry reactions and are responsible to many physiology and pathology processes. Protease inhibitors therefore have emerged as potent therapeutic agents for various diseases. Successful examples include Cathepsin inh...

Full description

Bibliographic Details
Main Author: Hu, X.
Published: Queen's University Belfast 2012
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557630
id ndltd-bl.uk-oai-ethos.bl.uk-557630
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5576302015-03-20T04:52:50ZDesign, synthesis and evaluation of inhibitors against tumour-associated proteaseHu, X.2012Proteases are a class of physiologically active proteins which lead different biochemistry reactions and are responsible to many physiology and pathology processes. Protease inhibitors therefore have emerged as potent therapeutic agents for various diseases. Successful examples include Cathepsin inhibitors and HIV aspartste protease inhibitors, while the matrix metalloproteinase inhibitors are deemed to be failure examples. In this thesis, a series of inhibitors of two distinct proteases seprase and proteasome were designed, synthesized and evaluated through different methods. The assessment of methodologies and clinical applications was also provided in guiding the future works.616.994Queen's University Belfasthttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557630Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.994
spellingShingle 616.994
Hu, X.
Design, synthesis and evaluation of inhibitors against tumour-associated protease
description Proteases are a class of physiologically active proteins which lead different biochemistry reactions and are responsible to many physiology and pathology processes. Protease inhibitors therefore have emerged as potent therapeutic agents for various diseases. Successful examples include Cathepsin inhibitors and HIV aspartste protease inhibitors, while the matrix metalloproteinase inhibitors are deemed to be failure examples. In this thesis, a series of inhibitors of two distinct proteases seprase and proteasome were designed, synthesized and evaluated through different methods. The assessment of methodologies and clinical applications was also provided in guiding the future works.
author Hu, X.
author_facet Hu, X.
author_sort Hu, X.
title Design, synthesis and evaluation of inhibitors against tumour-associated protease
title_short Design, synthesis and evaluation of inhibitors against tumour-associated protease
title_full Design, synthesis and evaluation of inhibitors against tumour-associated protease
title_fullStr Design, synthesis and evaluation of inhibitors against tumour-associated protease
title_full_unstemmed Design, synthesis and evaluation of inhibitors against tumour-associated protease
title_sort design, synthesis and evaluation of inhibitors against tumour-associated protease
publisher Queen's University Belfast
publishDate 2012
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.557630
work_keys_str_mv AT hux designsynthesisandevaluationofinhibitorsagainsttumourassociatedprotease
_version_ 1716787371433787392